Archive for the ‘Lymphoma / Leukemia’ Category
Thursday, May 15th, 2008
A new study by UC Davis researchers provides evidence that methods using human bone marrow-derived stem cells to deliver gene therapy to cure diseases of the blood, bone marrow and certain types of cancer do not cause the development of tumors or leukemia. The study was published online in the ...
Posted in Lymphoma / Leukemia | No Comments »
Thursday, May 15th, 2008
A study performed by researchers at the Institute for Research in Biomedicine (IRB Barcelona) on the fruit fly, Drosophila melanogaster, unveils how distinct signaling pathways operate between neighboring cells in order to activate the cell proliferation machinery that results in the organized growth of the fly wing. The signaling pathways ...
Posted in Lymphoma / Leukemia | No Comments »
Sunday, April 6th, 2008
Non-Hodgkin lymphoma is one of the most rapidly increasing types of cancer diagnosed in the United States with new diagnoses having more than doubled since the 1970s. However, over the past 10 years, mortality rates have begun to decline, indicating that progress is being made in its treatment.According to the ...
Posted in Lymphoma / Leukemia | No Comments »
Monday, March 31st, 2008
Leukaemia Research is celebrating having raised ￡500,000 in record time, thanks to the support of Argos employees and customers. Just seven months into the year-long charity partnership, Argos have raised enough funds to support a special cytogenetic database, which will record symptoms and treatments of different types of blood cancer ...
Posted in Lymphoma / Leukemia | No Comments »
Friday, March 28th, 2008
Since the 1990s, the survival rates for patients with non-Hodgkinlymphoma (NHL) appear to have increased, according to a reportpublished in the March 10 issue of the Archives of InternalMedicine, one of the JAMA/Archives journals. Non-Hodgkin's lymphoma is a set of different cancers of the lymphocytesin the immune system, and they ...
Posted in Lymphoma / Leukemia | No Comments »
Friday, March 28th, 2008
Genzyme Corp. (Nasdaq: GENZ) announced the withdrawal of the European application to extend the Evoltra(R) (clofarabine) product label to include the treatment of elderly patients with acute myeloid leukemia (AML). This application and the data on which it was based were filed by Bioenvision, Ltd. before the company was ...
Posted in Lymphoma / Leukemia | No Comments »
Tuesday, March 25th, 2008
Oregon Health & Science University Cancer Institute researchers have found that an experimental drug known as SGX393 is effective against Gleevec-resistant chronic myeloid leukemia (CML). The results of their study will be published the week of March 24th in the Proceedings of the National Academy of Sciences.Gleevec, the targeted therapy ...
Posted in Lymphoma / Leukemia | No Comments »
Monday, March 24th, 2008
The dramatic increase that has occurred in the cure rate for children with acute lymphoblastic leukemia (ALL) will be difficult to replicate in older patients without considerable additional research, according to an article by St. Jude Children's Research Hospital authors that appears in the March 22 issue of the Lancet.In ...
Posted in Lymphoma / Leukemia | No Comments »
Thursday, March 20th, 2008
The European Medicines Agency (EMEA) has been formally notified by Bioenvision Ltd, a whollyowned subsidiary of Genzyme Corporation, of its decision to withdraw its application for an extensionof indication for the centrally authorised medicine Evoltra (clofarabine). Evoltra was expected to be used for the treatment of acute myeloid leukaemia in ...
Posted in Lymphoma / Leukemia | No Comments »
Monday, March 17th, 2008
Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) announced the initiation of a multi-center, Phase II trial to evaluate VELCADE in combination with emerging agent, bendamustine, and current standard of care, rituximab, in patients with relapsed follicular lymphoma, a subset of non-Hodgkin's lymphoma (NHL). This trial is part of the Company's comprehensive development ...
Posted in Lymphoma / Leukemia | No Comments »
Monday, March 17th, 2008
Cephalon, Inc. (Nasdaq: CEPH) announced that the U.S. Food and Drug Administration (FDA) has accepted the company's new drug application (NDA) for TREANDA(R) (bendamustine HCl) for Injection for the treatment of patients with indolent B-cell non-Hodgkin's lymphoma (NHL) who have progressed during or following treatment with rituximab or a rituximab-containing ...
Posted in Lymphoma / Leukemia | No Comments »
Monday, March 17th, 2008
Xencor, Inc., a company developing protein and antibody therapeutics, has initiated a Phase I clinical trial with its lead product candidate XmAb™2513 in patients with Hodgkin lymphoma (HL) and Anaplastic Large Cell Lymphoma (ALCL). XmAb2513 is a humanized monoclonal antibody that targets the antigen CD30. It is engineered to contain ...
Posted in Lymphoma / Leukemia | No Comments »
Monday, March 17th, 2008
Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, announced the publication of a comprehensive review article entitled, "BiTE: A new class of antibodies that recruit T cells" in the journal Drugs of the Future. BiTE(R) antibodies ...
Posted in Lymphoma / Leukemia | No Comments »
Thursday, March 6th, 2008
Solving a long-standing biological mystery, UCLA stem cell researchers have discovered that blood stem cells, the cells that later differentiate into all the cells in the blood supply, originate and are nurtured in the placenta.The discovery may allow researchers to mimic the specific embryonic microenvironment necessary for development of blood ...
Posted in Lymphoma / Leukemia | No Comments »
Thursday, February 28th, 2008
The National Institute for Health and Clinical Excellence (NICE) issued final guidance recommending the use of MabThera(R) (rituximab), as a maintenance therapy for patients with relapsed/refractory follicular non-Hodgkin lymphoma (NHL) responding to induction therapy with chemotherapy with or without rituximab. 1 This is an important breakthrough as it represents a ...
Posted in Lymphoma / Leukemia | No Comments »